Franklin Coulter
Family Medicine · Orangeburg, SCNPI 1730103144
Payments from drug & device makers
Across 237 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$619
- Sanofi-aventis U.S. LLC$455
- Novartis$394
- Lilly USA, LLC$286
- Merck$262
- Avanir Pharmaceuticals, Inc.$244
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,90999%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $619 |
| Sanofi-aventis U.S. LLC | 28 | $455 |
| Novartis | 23 | $394 |
| Lilly USA, LLC | 17 | $286 |
| Merck | 16 | $262 |
| Avanir Pharmaceuticals, Inc. | 14 | $244 |
| Xeris Pharmaceuticals, Inc. | 10 | $176 |
| Bayer | 9 | $166 |
| Novo Nordisk | 11 | $158 |
| Boehringer Ingelheim | 7 | $144 |
| Amarin Pharma, Inc. | 9 | $144 |
| Johnson & Johnson | 6 | $102 |
| Acadia Pharmaceuticals Inc | 6 | $98 |
| GSK | 6 | $83 |
| Valeritas, Inc. | 5 | $82 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Indivior Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Pfizer | 3 | $45 |
| Biogen | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
| Exact Sciences | 1 | $19 |
| Abbott | 1 | $18 |
| Urovant Sciences Inc | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Encore Dermatology Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $12 |
How this compares
$3,965 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 44 | $95,072 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 104 | $67,895 |
| EntrestoSacubitril/Valsartan | 83 | $64,773 |
| TrulicityDulaglutide | 37 | $58,744 |
| JanuviaSitagliptin Phosphate | 49 | $48,108 |
| OzempicSemaglutide | 37 | $46,801 |
| MounjaroTirzepatide | 40 | $43,046 |
| FarxigaDapagliflozin Propanediol | 51 | $42,356 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 11 | $42,183 |
| EliquisApixaban | 59 | $39,926 |
| JanumetSitagliptin Phos/Metformin Hcl | 44 | $30,916 |
| XareltoRivaroxaban | 46 | $29,997 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 35 | $29,344 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,773 |
| Bydureon BciseExenatide Microspheres | 24 | $19,873 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanumet Xr, Januvia, Janumet, Steglujan | $262 | $153,559209 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $286 | $101,79077 claims |
| NovartisEntresto | $394 | $64,77383 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $619 | $55,56988 claims |
| Novo NordiskOzempic | $158 | $46,80137 claims |
| PfizerEliquis | $45 | $39,92659 claims |
| Boehringer IngelheimTradjenta, Jardiance, Synjardy Xr | $144 | $35,49756 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $83 | $30,16253 claims |
| Johnson & JohnsonXarelto | $102 | $29,99746 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $455 | $29,34435 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $22 | $16,94712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Orangeburg
- Monnieque SingletonOrangeburg$34K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.